Conversion of haemodialysis patients from iron sucrose to iron isomaltoside: a real-world experience

BACKGROUND: Anaemia is common in haemodialysis (HD) patients and associated with significant morbidity and mortality. Intravenous (IV) iron combined with erythropoiesis-stimulating agents (ESA) is the mainstay treatment of anaemia in these patients. The comparative efficacy and risk of adverse event...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Nephrol
Hauptverfasser: Jesus-Silva, Jorge A., Lamplugh, Archie, Dhada, Sameera, Burton, James O., Bhandari, Sunil
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2020
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7271492/
https://ncbi.nlm.nih.gov/pubmed/32493240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-01866-x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge